Innovative methods for balancing the benefits and risks of radiotherapy for Hodgkin lymphoma
- 8 September 2025 to 2 December 2025
- Project No: D26011
- DPhil Project 2026
- Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU)
Background
Hodgkin lymphoma (HL) is a blood cancer that is sensitive to a variety of treatments and generally has an excellent cure rate. The modern emphasis is now on optimising and risk-adapting management strategies to reduce the long-term side effects whilst maintaining the chance of cure. This project will; 1) develop a method of detecting HL recurrence in English population-based data to help quantify the efficacy of available treatment options and, 2) develop a tool to predict the long-term risks of radiotherapy at the time of diagnosis, i.e. before the individual patient’s treatment strategy is decided.
research experience, research methods and skills training
As part of the project the student will receive training in a variety of areas including practical research skills, radiation dosimetry, clinical epidemiology, data management and analysis.
FIELD WORK, SECONDMENTS, INDUSTRY PLACEMENTS AND TRAINING
Any required training will be provided based on the experience and needs of the individual candidate.
PROSPECTIVE STUDENT
The ideal candidate will have:
- A good grounding in radiation oncology
- An interest in epidemiology and statistics
- The ability to work both independently/show initiative and work within a team
- Excellent communication, organisational and presentation skills